BiBB reports positive results from clinical pilot study with EndoDrill URO
The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company") today reports that the first clinical study with EndoDrill[®] URO for muscle-invasive bladder cancer has been scientifically published in European Urology Open Science. The study shows that EndoDrill[®] URO safely can take treatment-based tissue samples earlier in the care chain in case of suspicion of deep-growing tumors in the urinary bladder. The research group concludes that it is now warranted to follow up the pilot study with a randomized efficacy study, which is already planned and regulatory approved."It is